SCHEMBL3702993

SCHEMBL3702993

C=C1c2ccccc2Sc2ccccc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.43
HPGD P15428 3/20 0.43
KDM4E B2RXH2 2/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
GPR84 Q9NQS5 1/20 0.41
ADORA3 P0DMS8 3/20 0.40
SLC6A2 P23975 3/20 0.40
SLC6A3 Q01959 3/20 0.40
TDP1 Q9NUW8 3/20 0.40
CYP3A4 P08684 3/20 0.40
MAOA P21397 2/20 0.40
CYP1A2 P05177 2/20 0.40
PTGS1 P23219 2/20 0.40
MAPT P10636 2/20 0.40
MEN1 O00255 1/20 0.40
BCHE P06276 1/20 0.40
POLB P06746 1/20 0.40
GAA P10253 1/20 0.40
ALOX15 P16050 1/20 0.40
ALOX12 P18054 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23954120 0.83 HPGD (0.53) HPGDL3MBTL1GPR84ADORA3SLC6A2
SCHEMBL23954282 0.82 GPR84 (0.43) ALDH1A1HPGDKDM4EGPR84ADORA3
SCHEMBL22809963 0.82 MEN1 (0.51) ALDH1A1HPGDKDM4EGPR84ADORA3
SCHEMBL19537629 0.79 ALDH1A1 (0.48) ALDH1A1HPGDKDM4EL3MBTL1GPR84
SCHEMBL17073678 0.79 ALDH1A1 (0.48) ALDH1A1HPGDKDM4EL3MBTL1GPR84
SCHEMBL17933494 0.79 ALDH1A1 (0.41) ALDH1A1HPGDKDM4EL3MBTL1GPR84
SCHEMBL13444642 0.78 NR1H3 (0.48) HPGDL3MBTL1ADORA3SLC6A2SLC6A3
SCHEMBL23954237 0.78 GPR84 (0.42) GPR84SLC6A2SLC6A3CYP3A4CYP1A2
SCHEMBL16363784 0.77 ADORA3 (0.52) ALDH1A1HPGDKDM4EL3MBTL1GPR84
SCHEMBL21588586 0.75 CYP1A2 (0.33) ALDH1A1HPGDKDM4EL3MBTL1GPR84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 109 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116854552-A Polysubstituted olefin and preparation method thereof 苏州华道生物药业股份有限公司 2023-10-10 CN claimed
US-7008990-B2 Use of polymeric reaction product BASF AKTIENGESELLSCHAFT (DE) 2006-03-07 US claimed
US-20040034182-A1 Method for the production of a polymerisation reaction product BASF AKTIENGESELLSCHAFT (DE) 2004-02-19 US claimed
US-20030170306-A1 Use of polymeric reaction product BASF AKTIENGESELLSCHAFT (DE) 2003-09-11 US claimed
EP-1294775-A1 METHOD FOR THE PRODUCTION OF A POLYMERISATION REACTION PRODUCT BASF AKTIENGESELLSCHAFT (DE) 2003-03-26 EP claimed
EP-1294786-A2 USE OF A POLYMER REACTION PRODUCT BASF AKTIENGESELLSCHAFT (DE) 2003-03-26 EP claimed
WO-2001098373-A1 METHOD FOR THE PRODUCTION OF A POLYMERISATION REACTION PRODUCT BASF AKTIENGESELLSCHAFT (DE) 2001-12-27 WO claimed
WO-2001096408-A2 USE OF A POLYMER REACTION PRODUCT BASF AKTIENGESELLSCHAFT (DE) 2001-12-20 WO claimed
US-11829036-B2 Optically anisotropic multilayer product and method for producing same ZEON CORPORATION (JP) 2023-11-28 US disclosed
CN-116854552-A Polysubstituted olefin and preparation method thereof 苏州华道生物药业股份有限公司 2023-10-10 CN disclosed
US-11697695-B2 Polymerizable composition and optically anisotropic body using same DIC CORPORATION (JP) 2023-07-11 US disclosed
US-11697695-B2 Polymerizable composition and optically anisotropic body using same DIC CORPORATION (JP) 2023-07-11 US disclosed
EP-3674757-B1 POLYMERIZABLE LIQUID CRYSTAL MATERIAL, POLYMERIZABLE LIQUID CRYSTAL COMPOSITION, POLYMER, OPTICAL FILM, OPTICAL ANISOTROPIC BODY, POLARIZER, ANTIREFLECTIVE FILM, DISPLAY DEVICE AND METHOD FOR MANUFACTURING POLYMERIZABLE LIQUID CRYSTAL COMPOSITION ZEON CORP (JP) 2022-04-20 EP disclosed
US-11186669-B2 Polymerizable composition and optically anisotropic body using same DIC CORPORATION (JP) 2021-11-30 US disclosed
EP-1294843-A1 WASHING ACTIVE PREPARATION BASF AKTIENGESELLSCHAFT (DE) 2003-03-26 EP disclosed
EP-1294786-A2 USE OF A POLYMER REACTION PRODUCT BASF AKTIENGESELLSCHAFT (DE) 2003-03-26 EP disclosed
EP-1294775-A1 METHOD FOR THE PRODUCTION OF A POLYMERISATION REACTION PRODUCT BASF AKTIENGESELLSCHAFT (DE) 2003-03-26 EP disclosed
WO-2001098373-A1 METHOD FOR THE PRODUCTION OF A POLYMERISATION REACTION PRODUCT BASF AKTIENGESELLSCHAFT (DE) 2001-12-27 WO disclosed
WO-2001096515-A1 WASHING ACTIVE PREPARATION BASF AKTIENGESELLSCHAFT (DE) 2001-12-20 WO disclosed
WO-2001096408-A2 USE OF A POLYMER REACTION PRODUCT BASF AKTIENGESELLSCHAFT (DE) 2001-12-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030170306-A1 Use of polymeric reaction product OXSR1, OGFR, CBR1 ALDH1A1 2250/4885HPGD 2951/4885KDM4E 2676/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.